Free Trial
NASDAQ:NTHI

Neonc Technologies (NTHI) Stock Price, News & Analysis

Neonc Technologies logo
$6.00 +0.01 (+0.17%)
As of 04:00 PM Eastern

About Neonc Technologies Stock (NASDAQ:NTHI)

Key Stats

Today's Range
$5.55
$6.06
50-Day Range
N/A
52-Week Range
$5.21
$25.00
Volume
37,640 shs
Average Volume
54,298 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.

Receive NTHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neonc Technologies and its competitors with MarketBeat's FREE daily newsletter.

NTHI Stock News Headlines

NeOnc Technologies announces global patent portfolio totals 176
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
NeOnc Technologies appoints Heshmatpour as President
See More Headlines

NTHI Stock Analysis - Frequently Asked Questions

Neonc Technologies' stock was trading at $12.00 at the beginning of the year. Since then, NTHI stock has decreased by 50.0% and is now trading at $6.00.
View the best growth stocks for 2025 here
.

Neonc Technologies (NTHI) raised $52 million in an initial public offering (IPO) on Wednesday, March 26th 2025. The company issued 2,100,000 shares at a price of $25.00 per share. RBW Capital Partners (Division of Dawson James) acted as the underwriter for the IPO.

Shares of NTHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NTHI
Previous Symbol
NASDAQ:NTHI
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$83,000.00
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
N/A
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:NTHI) was last updated on 4/30/2025 by MarketBeat.com Staff
From Our Partners